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Mix and Match: Mono-substituted Hydrocarbon Diastereomer 
Combinations Reveal Stapled Peptides with High Structural 
Fidelity 
Fergus S. McWhinnie,[a],[b] Kristel Sepp,[a] Charlotte Wilson,[a] Tilo Kunath,[b] Ted R. Hupp,[c] Terry S. 
Baker,[d] Douglas R. Houston[e] and Alison N. Hulme*,[a] 
Abstract: Modified peptides such as stapled peptides, which replicate 
the structure of α-helical protein segments, represent a potential 
therapeutic advance. However, the 3D solution structure of these 
stapled peptides is rarely explored beyond the acquisition of CD data 
to quantify bulk peptide helicity; the detailed backbone structure which 
underlies this is typically undefined. Diastereomeric stapled peptides 
based on helical sections of three proteins (αSyn, Cks1 and CK1α) 
were generated; their overall helicity was quantified by CD; and the 
most helical peptide from each series was selected for structural 
analysis. Solution-phase models for the optimised peptides were 
generated using NMR-derived restraints and a modified CHARMM22 
force field. Comparing these models with PDB structures allowed 
deviation between the stapled peptides and critical helical regions to 
be evaluated. These studies demonstrate that CD alone is not 
sufficient to assess the structural fidelity of a stapled peptide. 
The development of biorthogonal ‘staples’ which confer stable, 
α-helical secondary structure on peptides has reinvigorated 
research into the field of proteomimetics.[1] Short helical 
sequences are frequently found at protein-protein interfaces, 
suggesting that these interactions may be effectively modulated 
by stapled peptides.[2] Typically, staples bridge from amino acid 
residues i to i + 3, i + 4 and i + 7, and can be formed using a 
variety of different chemistries.[3] Stapled peptides are generally 
more cell permeable and resistant to proteolysis than their native 
counterparts.[4] With the synthesis of all-hydrocarbon α,α’-di-
substituted staples almost routine using recently-established 
protocols,[5] stapled peptides have already been validated as 
important tools in medicinal chemistry and their therapeutic 
potential is currently being explored.[6] However, anecdotal 
evidence suggests that following published protocols for amino 
acid substitution can fail to produce helical, bioactive peptides, 
even with extensive refinement of staple position.[7] Furthermore, 
studies in this field often lack robust structural comparison of the 
engineered helical peptides to their native protein, which might 
provide vital clues where only modest bioactivity is observed.[8] 
Peptide fragments amenable to a stapling strategy were 
extracted from three disease-relevant proteins which have ill-
defined functions in vivo: a 14-mer from the protein alpha-
synuclein (αSyn) key to the pathogenesis of Parkinson’s disease 
(Figure 1A);[9] a 12-mer from the accessory protein cyclin-
dependent kinase regulatory subunit 1 (Cks1) part of the E3 
ubiquitin ligase SCFSkp2, implicated in cancer (Figure 1B);[10] and 
a 10-mer from casein kinase 1 alpha (CK1α) a serine/threonine 
kinase involved in phosphorylation of the oncogenic protein 
MDM2 (Figure 1C).[11] Analysis of published biological data for 
each these targets enabled the identification of non-essential 
residues which could be substituted without perturbing functional 
activity.[12] Whilst screening using the de novo secondary 
structure predictor PEP-FOLD[13] allowed the extent to which 
these residues conferred helical peptide structure to be assessed. 
Using the results of these biological and conformational analyses, 
appropriate i to i + 4 stapling sites for a standard 8-atom linker 
were identified for each peptide.[3,14b] 
 
Scheme 1. Robust, facile and highly stereospecific monomer production.
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Figure 1. Proteins featured in the stapling campaign. Regions shown in red are those chosen for staple incorporation. (A) αSyn shown in the horse-shoe 
conformation which results from its interaction with small unilaminar vesicles (PDB ID: 1XQ8). (B) Cks1 from its crystal structure co-bound with the E3 ubiquitin 
ligase SCFSkp2 (PDB ID: 2AST). (C) Homology model for CK1α based on the protein CK1δ (PDB ID: 1CKI_A) produced using SWISS-MODEL. 
 
Scheme 2. Routes to ring closure 
An attractive alternative to α,α’-disubstituted ring closing 
metathesis (RCM) staple precursors is the use of simpler mono- 
substituted analogues.[14] To generate the most helical stapled 
peptide analogue of each of the targets using solid phase peptide 
synthesis (SPPS), ready access to Fmoc-protected precursor XS 
(1, Scheme 1) and its enantiomer XR (ent-1) was required. 
Current syntheses of 1 are lengthy,[15] are not readily applied to 
the synthesis of ent-1, and are not always reproducible.[16] Phase-
transfer catalyzed (PTC) alkylation of a glycine Schiff base using 
pseudo-enantiomeric pairings of catalysts derived from cinchona 
alkaloids has been used for the synthesis of a range of non-
natural α-amino acids and offers a viable alternative.[17] Glycine 
Schiff base 2 was alkylated in the presence of cinchona based 
PTC 3a at low temperature to give alkene 4 in quantitative yield; 
PTC 3b provided the enantiomeric adduct. Treatment of 4 with 
mild aqueous acid gave the free amine 5 which was Fmoc-
protected under basic conditions. The enantiopurity of 
intermediates 6 (94 %ee), and ent-6 (94 %ee), was established 
by reference to a racemic standard. Deprotection of the tert-butyl 
ester gave the required monomers 1 and ent-1 in 89% and 87% 
overall yield respectively. 
For each of the three peptide candidates (αSyn, Cks1 and 
CK1α; Figure 1), all possible diastereomers of staple precursor 
(XS,XS; XR,XR; XS,XR; XR,XS) were incorporated by SPPS at the 
staple sites identified. Attempted on-resin RCM staple formation 
with Grubbs I catalyst was unsuccessful in dichloroethane.[18] 
However, switching to a more helix-promoting solvent mixture 
(CH2Cl2:CF3CH2OH)[19] gave excellent conversion for cyclisation 
(>80% as determined by HPLC following resin micro-cleavage) 
across the series (Scheme 2). Under these on-resin conditions 
the stapled peptide was produced as a readily separable mixture 
of cis and trans isomers, favoring the cis isomer (cis:trans typically 
80:20).[20] Alternatively, the RCM reaction could be performed in 
comparable isolated yields on the fully-deprotected, cleaved 
peptides using the 2nd generation Hoveyda-Grubbs catalyst in 
trifluoroethanol. These solution phase RCM conditions gave only 
the cis isomer of the staple, however they were not compatible 
with cysteine or methionine residues. 
With the cis-stapled peptides in hand we assessed the effect 
of the stapling stereo-relationships on secondary structure. 
Circular dichroism in pure water gave only random coil structures. 
In contrast, in the presence of 25% trifluoroethanol, typically used 
as a co-solvent to mimic microsolvation effects from protein 
tertiary structure and known to induce formation of the micelle-
bound, helical form of the amphipathic protein αSyn,[21] marked 
differences in structure were observed between the native and 
diastereomeric stapled peptides (Figure 2). As expected, both the 
14-mer αSyn and 12-mer Cks1 native peptides were poorly helical 
under these conditions. However, the 10-mer CK1α native 
peptide gave unexpectedly high helicity. For the αSyn stapled 
peptides, the XS,XR relative configuration was most helical, XS,XS  






Figure 2. Effect of stapling stereo-relationships on peptide helicity. (A) CD 
spectra of peptide diastereomers in 25% TFE(aq) at 25 ºC for each peptide 
candidate. (B) Heat map of percentage helicity for each peptide calculated using 
DichroWeb algorithms.[22] 
gave moderate helicity, while other configurations gave very little 
enhancement. More modest helicities were observed for the Cks1 
stapled peptides, where in contrast to the αSyn series, the most 
helical combination was XS,XS, while XS,XR was least helical. 
Finally, looking at the stapled peptides from CK1α we found that 
the XS,XS diastereomer was the most helical, whilst both the XR,XR 
and XS,XR peptides were more structurally disordered than the 
native peptide. This empirical synthetic approach, allowed us to 
select stapled peptides with moderate to good helicity for 
subsequent NMR and modelling studies. 
To acquire an accurate backbone model of these stapled 
peptides (αSyn, XS,XR; Cks1 & CK1α, XS,XS), high concentration 
samples (7 mM) were used in natural abundance 1H-15N HSQC 
and COSY which allowed the unambiguous assignation of 
backbone NH signals. In tandem with NOESY, these spectra 
allowed the identification of ~100 distance and angle restraints 
per peptide (SI Figure 2), many arising from classic α-helical 
relationships. An ensemble of energy minimized backbone 
structures was produced in Xplor-NIH using a modified 
CHARMM22 force field to accommodate the mono-substituted 
staple,[23] in combination with these experimentally determined 
restraints.[24] Averaging these ensembles showed only modest 
deviation of peptide backbone configuration between the 10 
lowest energy models (RMSD; αSyn 1.4 Å, Cks1 1.0 Å, CK1α 1.3 
Å), giving us reasonable confidence in these structures.[25] 
Computational modelling of helical stapled peptides based on 
NMR solution data has been accomplished previously, however, 
these models have not been compared with data for their parent 
protein structures to confirm the production of an accurate helical 
mimic.[26] Therefore, NMR-refined solution structures of the helical  
 
Figure 3. NMR refined solution structures of (A) αSyn, (B) Cks1 and (C) CK1α 
peptides. Left: the averaged models were backbone aligned with their parent 
protein and their deviation defined, RMSD (A) αSyn 1.3 Å; (B) Cks1 0.4 Å; (C) 
CK1α 0.4 Å. Right: side-chains known to be critical to protein bioactivity are 
indicated by space-filling and do not appear to clash sterically with the peptide 
staple. 
peptides were compared with the corresponding PDB data to 
assess backbone homology (Figure 3 (left)).[27] Using full 
backbone alignment, we found close structural agreement 
between the stapled peptides and parent proteins.[28] Of note, for 
the Cks1:Skp2 interaction, the interacting sequence from Cks1 is 
comprised of 60% helix and 40% loop residues, and the backbone 
alignment shows that a moderately helical stapled peptide (only 
37% by CD analysis) can be highly homologous with a critical 
helical region of its parent protein (RMSD 0.4 Å over aa’s 39-46). 
These data demonstrate that screening using coarse-grained 
techniques such as CD alone is not sufficient to assess the 
potential of a stapled peptide. Moreover, using space filling 
models we could demonstrate both that the peptides display 
critical residues in the desired relative orientation with 
comparatively low RMSD values (SI Table 1 and SI Figure 3),[29,30] 
and that interference from the unnatural staple in these peptides 
was minimized (Figure 3 (right)). Thus, this rapid acquisition 
method produces a reliable backbone representation of these 
constrained peptides and would provide a structural basis to 
inform any later observed bioactivity. 
In conclusion, this rapid and accessible protocol facilitates the 
identification of stapled peptides with backbone structures which 
replicate that of the parent protein with high fidelity. These 
techniques could be applied to any helical protein target enabling 
pre-validation of synthesized material before in vitro or in vivo 
analysis. We anticipate this approach will enable a deeper 
understanding of specific protein-protein interactions, and provide 
a structural rationale for the observed effects of stapled peptides. 
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